Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review
Preventive transhepatic tract embolisation (PTTE) after percutaneous biliary intervention (PBI) may reduce adverse events. The aim of this systematic review was to analyse feasibility, safety, and efficacy of PTTE with different embolic agents. A systematic literature research was performed accordin...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2020/8849284 |
id |
doaj-d6e5d18443ad4cfba3d9990f1ce182c8 |
---|---|
record_format |
Article |
spelling |
doaj-d6e5d18443ad4cfba3d9990f1ce182c82020-11-25T02:25:56ZengHindawi LimitedCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972020-01-01202010.1155/2020/88492848849284Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic ReviewDaniel Schmitz0De-Hua Chang1Jochen Rudi2Svetlana Hetjens3Matthias P. A. Ebert4Department of Gastroenterology, Oncology and Diabetology, Theresienkrankenhaus und St. Hedwigsklinik GmbH, Heidelberg University, Bassermannstr.1, 68165 Mannheim, GermanyDepartment of Medical Statistics, Biomathematics and Information Processing, Mannheim University Hospital, Ludolf-Krehl-Str. 13-17, 68165 Mannheim, GermanyDepartment of Gastroenterology, Oncology and Diabetology, Theresienkrankenhaus und St. Hedwigsklinik GmbH, Heidelberg University, Bassermannstr.1, 68165 Mannheim, GermanyDepartment of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, GermanyDepartment of Medicine II, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, GermanyPreventive transhepatic tract embolisation (PTTE) after percutaneous biliary intervention (PBI) may reduce adverse events. The aim of this systematic review was to analyse feasibility, safety, and efficacy of PTTE with different embolic agents. A systematic literature research was performed according to the PRISMA guidelines. The identified studies were analysed concerning study quality, number of cases, indication, embolic agent, embolisation technique, success, and embolisation-related adverse events. Out of 62 identified records, 7 studies of mainly moderate study quality published through 2019 were included for further analysis. Cyanoacrylate (n = 4), gelatin sponge (n = 2), and coils (n = 1) were used as embolic agents in a total number of 314 patients. Technical success was 96–100%. Embolisation-related adverse events (glue migration, pain) occurred in 10/314 (3.2%) patients. Reduction of PBI-related pain was approved by one controlled study; haemorrhage events were reduced but not clearly significant. Overall, biliary leak, transhepatic bleeding, and PBI-related pain occurred in 7/201 (3.5%), 1/293 (0.3%), and 17/46 (36.9%) documented patients after PTTE. Adverse events which likely could not have been prevented by PTTE occurred in 23/180 (12.8%) patients. Embolic agents were not compared. In conclusion, PTTE is feasible and safe. It is effective concerning the prevention of PBI-related pain, and it may be effective concerning haemorrhage. Prevention of biliary leak is not proven. It remains unclear which embolic agent should be preferred. A prospective randomised trial including all preventable adverse events is lacking.http://dx.doi.org/10.1155/2020/8849284 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daniel Schmitz De-Hua Chang Jochen Rudi Svetlana Hetjens Matthias P. A. Ebert |
spellingShingle |
Daniel Schmitz De-Hua Chang Jochen Rudi Svetlana Hetjens Matthias P. A. Ebert Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review Canadian Journal of Gastroenterology and Hepatology |
author_facet |
Daniel Schmitz De-Hua Chang Jochen Rudi Svetlana Hetjens Matthias P. A. Ebert |
author_sort |
Daniel Schmitz |
title |
Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review |
title_short |
Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review |
title_full |
Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review |
title_fullStr |
Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review |
title_full_unstemmed |
Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review |
title_sort |
preventive transhepatic tract embolisation after percutaneous biliary interventions: a systematic review |
publisher |
Hindawi Limited |
series |
Canadian Journal of Gastroenterology and Hepatology |
issn |
2291-2789 2291-2797 |
publishDate |
2020-01-01 |
description |
Preventive transhepatic tract embolisation (PTTE) after percutaneous biliary intervention (PBI) may reduce adverse events. The aim of this systematic review was to analyse feasibility, safety, and efficacy of PTTE with different embolic agents. A systematic literature research was performed according to the PRISMA guidelines. The identified studies were analysed concerning study quality, number of cases, indication, embolic agent, embolisation technique, success, and embolisation-related adverse events. Out of 62 identified records, 7 studies of mainly moderate study quality published through 2019 were included for further analysis. Cyanoacrylate (n = 4), gelatin sponge (n = 2), and coils (n = 1) were used as embolic agents in a total number of 314 patients. Technical success was 96–100%. Embolisation-related adverse events (glue migration, pain) occurred in 10/314 (3.2%) patients. Reduction of PBI-related pain was approved by one controlled study; haemorrhage events were reduced but not clearly significant. Overall, biliary leak, transhepatic bleeding, and PBI-related pain occurred in 7/201 (3.5%), 1/293 (0.3%), and 17/46 (36.9%) documented patients after PTTE. Adverse events which likely could not have been prevented by PTTE occurred in 23/180 (12.8%) patients. Embolic agents were not compared. In conclusion, PTTE is feasible and safe. It is effective concerning the prevention of PBI-related pain, and it may be effective concerning haemorrhage. Prevention of biliary leak is not proven. It remains unclear which embolic agent should be preferred. A prospective randomised trial including all preventable adverse events is lacking. |
url |
http://dx.doi.org/10.1155/2020/8849284 |
work_keys_str_mv |
AT danielschmitz preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview AT dehuachang preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview AT jochenrudi preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview AT svetlanahetjens preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview AT matthiaspaebert preventivetranshepatictractembolisationafterpercutaneousbiliaryinterventionsasystematicreview |
_version_ |
1715488575520243712 |